Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Oncology Institute (TOI) Other Non Operating Income (2020 - 2025)

Oncology Institute's Other Non Operating Income history spans 6 years, with the latest figure at $1.1 million for Q4 2025.

  • For Q4 2025, Other Non Operating Income fell 61.91% year-over-year to $1.1 million; the TTM value through Dec 2025 reached -$12.2 million, down 552.58%, while the annual FY2025 figure was -$12.2 million, 552.58% down from the prior year.
  • Other Non Operating Income reached $1.1 million in Q4 2025 per TOI's latest filing, up from -$6.0 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $15.5 million in Q3 2022 to a low of -$6.0 million in Q3 2025.
  • Average Other Non Operating Income over 5 years is $1.1 million, with a median of $6500.0 recorded in 2024.
  • Peak YoY movement for Other Non Operating Income: skyrocketed 10962.5% in 2022, then tumbled 10767.27% in 2025.
  • A 5-year view of Other Non Operating Income shows it stood at -$80000.0 in 2021, then surged by 10962.5% to $8.7 million in 2022, then tumbled by 113.3% to -$1.2 million in 2023, then skyrocketed by 342.3% to $2.8 million in 2024, then crashed by 61.91% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for TOI's Other Non Operating Income are $1.1 million (Q4 2025), -$6.0 million (Q3 2025), and -$4.0 million (Q2 2025).